Cholangiocarcinoma is also a rare cancer with approximately 5,000 cases diagnosed each year in the US. Patients are usually in theirs sixties. Risk factors include primary sclerosing cholangitis, hepatolithiasis, choledochal cysts, or liver fluke infection. Symptoms include weigh loss, jaundice, right upper quadrant pain, fever, and palpable mass. Diagnosis and imaging include liver MRI, MRCP, or abdominal CT. An ERCP is often needed for diagnosis.
Treatment options include surgery, adjuvant chemotherapy, chemoradiation, radiofrequency ablation or chemotherapy alone. Chemotherapy agents include 5-FU, oxaliplatin, cisplatin, and gemzar.
Dr. Raymond Tsao completed his fellowship in Hematology & Medical Oncology at The Cleveland Clinic in Ohio.
He is board certified in Medical Oncology, Hematology, and Internal Medicine.
Dr. Tsao is currently seeing patients with all types of cancer, with a focus on Gastrointestinal Malignancies (including esophageal, stomach, colorectal, and pancreatic cancer). Click here to learn more about Dr. Raymond Tsao.
Dina Giovanetti received her BSN in 1994 and her MSN in 2002 from Florida Atlantic University. She is Board Certified as a Family Nurse Practitioner and has practiced in Internal Medicine and Emergency Medicine for most of her career before joining Cancer Center of South Florida and practicing Oncology. Click here to learn more about Dina Giovanetti.